Phosphoinositide-specific phospholipase C (PLC) activities were measured in CSF from patients af ter subarachnoid hemorrhage (SAH). Their PLC activi ties were significantly higher than those in control CSF. Moreover, there was an obvious correlation between the PLC activity in CSF collected on day 3 and the preoper ative clinical grade. The PLC activity was also closely correlated with the level of neuron-specific enolase as a marker of brain damage. Furthermore, the PLC activities
Phospholipase C Activity in Cerebrospinal Fluid Following
Subarachnoid Hemorrhage Related to Brain Damage Toshihiko Nakashima, Katsunobu Takenaka, Yasuaki Nishimura, Takashi Andoh, Noboru Sakai, Hiromu Yamada, *Yoshiko Banno, *Yukio Okano, and *Yoshinori Nozawa
Departments of Neurosurgery and *Biochemistry, Giju University School of Medicine, Giju, Japan Summary: Phosphoinositide-specific phospholipase C (PLC) activities were measured in CSF from patients af ter subarachnoid hemorrhage (SAH). Their PLC activi ties were significantly higher than those in control CSF. Moreover, there was an obvious correlation between the PLC activity in CSF collected on day 3 and the preoper ative clinical grade. The PLC activity was also closely correlated with the level of neuron-specific enolase as a marker of brain damage. Furthermore, the PLC activities Clinical outcome following aneurysmal subarach noid hemorrhage (SAH) is largely dependent upon the degree of brain damage caused by the initial hemorrhage and by delayed cerebral ischemia due to cerebral vasospasm (Hunt and Hess, 1968; Chyatte et aI., 1988) . However, in the early stage, the patient's condition is often affected by pharma cologically induced sedation employed as protec tion against aneurysmal rerupture, which makes the clinical evaluation difficult. Therefore, objective criteria are required for the estimation of brain dam age during the early stage after SAH. Although pre vious investigations have sought clinically useful markers, only two indicators, neuron-specific eno lase (NSE) and S-lOO protein (Persson et aI., 1988;  were partially purified from CSF of patients after SAH and were immunologically identified to be PLC�, PLC-y, and PLC8. These results suggest that PLCs are released into the CSF from brain tissue in conjunction with the initial hemorrhage and that their activity may reflect the extent of brain damage. Key Words: Brain damage Cerebrospinal fluid-Neuron-specific enolase Phosphoinositide-specific phospholipase C-Subarach noid hemorrhage. Hardemark et aI., 1989b) , have been proposed to be of some utility.
Phosphoinositide-specific phospholipase C (PLC) is known to play a crucial role in the transmem brane signaling of various cells (Berridge and Irv ine, 1984; Nishizuka, 1984) . Neurotransmitters, growth factors, and hormones bind to specific re ceptors on the external surface of cells. Receptor occupancy induces rapid breakdown of phospho inositide through the activation of PLC. The degra dation products of this enzyme reaction, inositol 1,4,5-trisphosphate and 1,2-diacylglycerol, act as second messengers involving the internal Ca2+ re lease and activation of protein kinase C, respec tively. PLC activity is present in a wide variety of tissues (Rhee et aI., 1989) . The concentration of PLC isozymes has been measured in several tis sues, and PLC� has been demonstrated to be al most specific for brain tissue (Suh et aI., 1988) . Furthermore, PLC� and PLC'Y were shown to be localized in neurons in the rat brain by an immuno histochemical study using monoclonal antibodies (Grefen et aI., 1988) . In this investigation, we mea sured the PLC activity in the CSF of patients after SAH and found that the enzyme activity was en hanced. A close correlation between the PLC ac-tivity in CSF and the extent of brain damage was observed.
MATERIALS AND METHODS

Clinical materials
Seventeen patients with ruptured intracranial aneu rysm were selected for this study. Any cases of SAH associated with intracerebral hematoma were excluded. The clinical grades of patients were evaluated according to the Hunt and Kosnik grading system (1974) . All pa tients underwent surgery within 48 h after the onset of SAH. An Ommaya reservoir was positioned, and its cath eter tip was inserted into the basal cistern of all patients at the time of aneurysm surgery. The day of aneurysm rup ture was designated as day O. The CSF samples were obtained by gentle aspiration through the Om maya reser voir on days 3, 6, 11, and 16. In three cases, CSF samples were collected from the basal cistern during surgery. Control CSF samples were obtained from five patients who had no organic disease in the central nervous sys tem. The collected CSF samples were centrifuged at 1,000 x g for 10 min at 4°C and stored at -80°C until assayed.
Materials and antibodies
PhosphatidylinositoI 4,5-bisphosphate (PIP2) and phos phatidylethanolamine (PE) were purchased from Sigma. eH]PIPz (specific activity 3.5 mCi/mmol) was obtained from DuPont-New England Nuclear. A fast protein liquid chromatography (FPLC) system equipped with Mono Q column (HR 10/10; Pharmacia LKB Biotechnology) was used for protein purification.
Specific antibodies for PLCJ1, PLC,,{, and PLC8 (Emori et aI., 1989) were generously supplied by Dr. T. Ta kenawa (Tokyo Metropolitan Institute of Gerontology).
Assay for PLC activity
PLC activity was assayed by measuring aqueous [3H]_ inositol 1,4,5-trisphosphate, a degradation product of eH]PIPz, as described previously (Banno et aI., 1988) . In brief, CSF (15 j.ll, �10-150 j.lg protein) was incubated in 20 mM Tris-maleate buffer (pH 6.8) containing 80 mM KCI, 2 mM ethyleneglycol-bis (J1-aminoethyl ether) N,N,N', N'-tetraacetic acid (EGTA), 1.66 mM CaClz, so dium deoxycholate (1 mg/ml), and eH]PIPz (17,000 dpm)/ PIPz (0.1 rnM)lPE (0.5 mM) in a total volume of 50 j.ll. After 15-min incubation at 37°C in a shaking water bath, the reaction was terminated by adding 0.25 ml of chloro form/methanol/concentrated HCl (100:100:0.6 by vol) and 0.1 ml of 5 mM EGTA/l N HCI solution. The mixture was vortex-mixed and then centrifuged at 2,000 g for 10 min. A 0.2-ml portion of the upper aqueous phase was care fully transferred to a vial and mixed with 6 ml of scintil lation fluid, and radioactivity was measured in a liquid scintillation counter (Beckman LS-9000).
The water-soluble reaction products were analyzed by chromatography on Dowex 1 x 8 according to a method described previously (Downes and Michell, 1981) . The radioactivities were eluted with 1.0 M ammonium for mate, with which inositol trisphosphate was to be eluted.
Partial purification of PLC from CSF
Partial purification of PLC was performed by a modi fication of the method described previously (Rath et aI., 1993 1990). In brief, bloody CSF (250 ml) was collected through the cisternal drainage system of a patient on day 3. The CSF was centrifuged at 1,000 g for 10 min at 4°C to remove contaminating red blood cells. The supernatant was concentrated to 50 ml in an Amicon concentrator (YM-1O membrane) for the subsequent step. Proteins in the concentrated CSF were fractionated with 55% satu rated ammonium sulfate. Precipitated portions were dis solved in buffer A [20 mM Tris-HCI (pH 7.6), 1 mM EGTA, and 0.1 mM dithiothreitol] and dialyzed against buffer A overnight at 4°C. The dialyzed solution was ap plied onto Mono Q column (HR 10/10) equilibrated with buffer A. The column was washed and eluted with an increasing KCl linear gradient from 0 to 0.45 M in buffer A for 60 min at a flow rate of 1 mllmin and then from 0.45 to 1 M in buffer A for 4 min using an FPLC system. Aliquots (15 j.ll) of each fraction (1 ml) were subjected in the PLC assay as described above. Active fractions of each activity peak were pooled, concentrated to a small volume, and stored at -80°C.
Electrophoresis and immunoblot analysis
Control CSF, CSF from a patient with SAH, and par tially purified PLC fractions were analyzed by 8% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) and stained with Coomassie blue as described previously (Laemmli, 1970) . Partially purified PLC frac tion was subjected to SDS-PAGE in 8% polyacrylamide gel, and immunoblotting was performed after transfer of proteins onto nitrocellulose sheets from polyacrylamide gels as described previously (Towbin et aI., 1970) . Nitro cellulose sheets were incubated overnight at 4°C with an tibodies for PLC isozymes J1, "{, and 8. Immunological detection of PLCJ1 and PLC,,{ was performed by a modi fication of the ABC method. Detection of PLC8 was per formed by the enhanced chemiluminescence method us ing the ECL Western blotting detection system (Amer sham).
Measurement of NSE content
NSE was determined by a Pharmacia RIA kit as de scribed previously (Pahlman et aI., 1984) . Human NSE was used as a standard and the antiserum used was raised against human NSE.
Statistical evaluation
Statistical evaluation was performed by unpaired Stu dent t test. The results were expressed as means ± SD. Significance was accepted for p < 0.01.
RESULTS
PLC activity and NSE level in CSF
The time courses of PLC activity in the CSF in five typical cases of SAH are shown in Fig. 1 . The highest PLC activities were obtained in CSF on day 3. Three other cases in which CSF was also col lected during surgery exhibited higher PLC activi ties in CSF on day 0 than on day 3 (data not shown). PLC activities in CSF rapidly decreased during the first 6 days and then gradually decreased.
The relationship between PLC activity in CSF collected on day 3 and the preoperative clinical grade following SAH was examined in 17 patients. The mean ± SD PLC activity of five control CSF samples was 72 ± 24 pmol/min/ml, while those of grades I, 2, and 3 were 267 ± 62, S3S ± 131, and 1,121 ± 86 pmollmin/ml, respectively. There was a positive correlation between PLC activities in the CSF on day 3 and the preoperative clinical grades of patients with SAH, as shown in Fig. 2 . The levels ofNSE in CSF collected on day 3 were also measured in 13 patients. A positive correlation between NSE concentration and PLC activity was observed (Fig. 3) . The coefficient correlation (r) be tween these two measurements was 0.9S2 (y O.13lx -31.S3S).
Partial purification and immunoblotting of PLC
When the CSF of a patient with SAH was sub jected to Mono Q column chromatography for par tial purification, four PLC activity peaks were re solved: a small peak (I) and three large peaks (II, III, and IV) (see Fig. 4 ). Active fractions of peak I and peaks II-IV were pooled in tubes A and B, respectively. Each of the samples was examined for the type of PLC isozyme by immunoblotting using specific antibodies. Protein patterns of CSF sam ples from the control, the patient with SAH on day 3, and a partially purified PLC fraction of CSF (A and B) are shown in Fig. SA . The partially purified PLC fraction of tube B contained proteins that cross-reacted with anti-PLCI3 antibody and anti PLCy antibody, but did not contain a protein that cross-reacted with anti-PLC8 antibody (Fig. SB) . Anti-PLCI3 antibody recognized 100-and SO-kDa polypeptides that were PLCI3 fragments derived from ISO-kDa PLCI3 (Rhee et aI., 1989) (Fig. SB,  lane 1) . Anti-PLC-y antibody cross-reacted with a band of 14S-kDa PLCy (Fig. SB, lane 2) . The frac tion of tube A contained protein that cross-reacted with anti-PLC8 antibody (Fig. SB, lane 3) . Anti PLC8 antibody cross-reacted with a band of 8S-kDa PLC8. were assayed for PLC activity.
DISCUSSION
Many substances are released into the CSF after various forms of brain damage. Recently, levels of NSE and S-lOO protein were measured in the CSF of patients with brain damage, and it was found that they could be of potential use as markers for de structive processes in the brain (Steinberg et aI., 1984; Persson et aI., 1987; Hardemark et aI., 1989a) .
The rupture of an aneurysm causing SAH gives rise to an extreme increase in intracranial pressure, followed by intracranial circulatory arrest lasting several minutes (Nornes, 1973) . Such an ischemic event may cause diffuse brain injury with patchy and diffuse neuronal loss or a localized lesion. The analysis of markers related to brain damage in the early stage after SAH has revealed that NSE or S-100 protein may be useful in predicting the extent 2 of brain damage caused by hemorrhage (Persson et aI., 1988; Hardemark et aI., 1989b) . In SAH pa tients, these two proteins seemed to be sensitive markers of brain damage, and their levels in CSF appeared to reflect the severity of the disease (Pers son et aI., 1987) . In this study, we have demonstrated marked el evations of PLC activity in CSF of patients follow ing SAH. It is known that the brain contains the three major PLC isozymes (13, -y, and 8) (Rhee et ai., 1989) . Chromatographic resolution of CSF on a Mono Q column yielded one small peak and three large peaks of PLC activity, suggesting multiple PLC isozymes. Immunoblot analysis demonstrated three types of PLC isozymes, PLCI3, PLC-y, and PLC8 in CSF from patients following SAH. Peak I (Fig. 4) contained a small amount of PLC8. Al though PLC8 was not detectable on blotting paper by the ABC method, it could be detected in the fractions of peak I by the enhanced chemilumines cence method, which was more sensitive than the ABC method. The fractions of three large activity peaks in Fig. 4 (fraction II, III, and IV) contained PLCI3 and PLC-y. One of the three large peaks might contain PLCI3, another PLC-y, and another a degraded product of PLCI3, because anti-PLCI3 an tibody recognized two immunoreactive bands (100 and 50 kDa) but no 150-kDa PLCI3 band was de tected (Fig. 5B, lane 1) . The 150-kDa PLCI3 was possibly degraded by repeated freezing and thaw ing. The content of PLCI3 is approximately 4 times higher than that of PLC-y (Grefen et aI., 1988) , and PLC-y is approximately 16 times more abundant than PLC8 (Suh et aI., 1988 ) in brain tissue. There fore, most of the activities in CSF were possibly due to PLCI3 and PLC-y derived from brain tissue. The present investigation demonstrated signifi cantly elevated PLC activity in CSF after SAH. The main PLC isozymes were identified as PLC� and PLC'Y. The enhancement of PLC activity was closely correlated with the NSE level in CSF and with the preoperative clinical grade (Hunt and Kosnik, 1974 ). An increase in S-100 and NSE levels in CSF after traumatic or focal ischemic brain damage has been reported (Steinberg et aI., 1984; Hardemark et aI., 1988 Hardemark et aI., , 1989a , and possible utility for the estimation of the extent of brain damage has been suggested. It is possible that PLC activity in CSF also increases after traumatic or focal ischemic brain damage. It is thus proposed that the PLC ac tivity in CSF from patients with SAH is a useful index not only for the estimation of the extent of brain damage caused by SAH but also for the pre diction of the course of disease.
